HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sung Gwe Ahn Selected Research

Drug Therapy (Chemotherapy)

10/2021Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer.
8/2021Application of the 21-Gene Recurrence Score in Patients with Early HR-Positive/HER2-Negative Breast Cancer: Chemotherapy and Survival Rate According to Clinical Risk.
4/2021Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer.
9/2018Protective effect of Korean red ginseng on oxaliplatin-mediated splenomegaly in colon cancer.
9/2017Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea.
1/2017Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.
6/2016Eribulin Mesylate Combined with Local Treatment for Brain Metastasis from Breast Cancer: Two Case Reports.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sung Gwe Ahn Research Topics

Disease

73Breast Neoplasms (Breast Cancer)
04/2024 - 12/2011
42Neoplasms (Cancer)
03/2024 - 01/2014
12Neoplasm Metastasis (Metastasis)
03/2024 - 08/2013
8Triple Negative Breast Neoplasms
05/2024 - 10/2017
5Pathologic Complete Response
02/2024 - 01/2018
4Lymphatic Metastasis
04/2024 - 01/2021
3Noninfiltrating Intraductal Carcinoma (DCIS)
04/2024 - 05/2012
2Margins of Excision
03/2024 - 12/2020
2Carcinogenesis
12/2022 - 12/2017
2Overweight
01/2022 - 01/2020
2Weight Loss (Weight Reduction)
01/2022 - 01/2020
2Disease Progression
04/2021 - 08/2020
2Inflammation (Inflammations)
01/2019 - 10/2017
2Brain Neoplasms (Brain Tumor)
01/2018 - 06/2016
1Contracture
02/2023
1Lymphopenia (Lymphocytopenia)
01/2023
1Residual Neoplasm
09/2022
1Obesity
01/2022
1Drug-Related Side Effects and Adverse Reactions
04/2021
1Insulin Resistance
01/2020
1Body Weight (Weight, Body)
01/2020
1Carcinoma (Carcinomatosis)
12/2019
1Splenomegaly
09/2018
1Colonic Neoplasms (Colon Cancer)
09/2018

Drug/Important Bio-Agent (IBA)

15Hormones (Hormone)IBA
03/2024 - 01/2014
14Estrogen ReceptorsIBA
02/2024 - 01/2013
10human ERBB2 proteinIBA
02/2024 - 06/2016
9Phenobarbital (Luminal)FDA Link
05/2024 - 01/2014
7Biomarkers (Surrogate Marker)IBA
12/2022 - 09/2015
6Glucose (Dextrose)FDA LinkGeneric
12/2022 - 01/2016
6Proteins (Proteins, Gene)FDA Link
10/2022 - 09/2018
4Trastuzumab (Herceptin)FDA Link
02/2024 - 01/2013
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2022 - 11/2011
4Immune Checkpoint InhibitorsIBA
06/2022 - 07/2021
3Epidermal Growth Factor (EGF)IBA
04/2024 - 01/2018
3Indicators and Reagents (Reagents)IBA
02/2024 - 01/2016
3ErbB Receptors (EGF Receptor)IBA
01/2023 - 09/2015
3Progesterone Receptors (Progesterone Receptor)IBA
01/2019 - 03/2014
2pertuzumabIBA
02/2024 - 10/2021
2Carboplatin (JM8)FDA LinkGeneric
02/2024 - 01/2023
2Transcription Factors (Transcription Factor)IBA
10/2023 - 01/2021
2atezolizumabIBA
06/2022 - 07/2021
2Formaldehyde (Formol)FDA Link
05/2022 - 07/2021
2ParaffinIBA
05/2022 - 07/2021
2Cyclin-Dependent Kinase 4IBA
08/2020 - 09/2018
2Estrogens (Estrogen)FDA Link
12/2019 - 12/2014
2UbiquitinIBA
01/2019 - 10/2017
2Aromatase InhibitorsIBA
12/2014 - 12/2011
2Zoledronic Acid (Zometa)FDA Link
12/2014 - 12/2011
1Androgen Receptors (Androgen Receptor)IBA
05/2024
11- methyl- 3- (4- (1- methylethyl)phenyl)- 2,5- pyrrolidinedione (BPMS)IBA
03/2024
1Docetaxel (Taxotere)FDA Link
02/2024
1Complement System Proteins (Complement)IBA
02/2024
1Matrix Metalloproteinases (MMPs)IBA
02/2024
1Chemokine ReceptorsIBA
01/2024
1LigandsIBA
08/2023
1pembrolizumabIBA
08/2023
1CollagenIBA
10/2022
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
01/2022
1CytokinesIBA
01/2022
1AntibodiesIBA
10/2021
1Letrozole (Femara)FDA LinkGeneric
04/2021
1CT-P6IBA
01/2021
1Biosimilar PharmaceuticalsIBA
01/2021
1TOR Serine-Threonine KinasesIBA
08/2020
1Insulin (Novolin)FDA Link
01/2020
1Naltrexone (ReVia)FDA LinkGeneric
01/2020
1Bupropion (Wellbutrin)FDA LinkGeneric
01/2020
1VimentinIBA
12/2019
1PolyubiquitinIBA
12/2019
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2019
1DNA (Deoxyribonucleic Acid)IBA
11/2018
1Methionine-tRNA LigaseIBA
09/2018
1Fluorouracil (Carac)FDA LinkGeneric
09/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2018
1Leucovorin (Folinic Acid)FDA Link
09/2018
1Cathepsin BIBA
12/2017
1Annexin A2 (Annexin II)IBA
12/2017
1Inhibitor of Apoptosis ProteinsIBA
10/2017
1EnzymesIBA
10/2017
1Arginine (L-Arginine)FDA Link
10/2017
1Lysine (L-Lysine)FDA Link
10/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017
1eribulinFDA Link
06/2016

Therapy/Procedure

19Neoadjuvant Therapy
04/2024 - 01/2015
11Radiotherapy
03/2024 - 03/2015
11Therapeutics
08/2023 - 12/2014
8Segmental Mastectomy (Lumpectomy)
04/2024 - 05/2012
7Mastectomy (Mammectomy)
04/2024 - 06/2018
7Drug Therapy (Chemotherapy)
10/2021 - 06/2016
5Adjuvant Radiotherapy
04/2024 - 05/2012
4Adjuvant Chemotherapy
02/2023 - 12/2013
2Lymph Node Excision (Lymph Node Dissection)
04/2024 - 04/2024
2Mediterranean Diet
01/2022 - 01/2020
1Surgical Instruments (Clip)
02/2024
1Mammaplasty (Breast Reconstruction)
02/2023
1Breast Implants (Breast Implant)
02/2023
1Contraindications
10/2021
1Operative Time
02/2020
1Simple Mastectomy
12/2019